αPD-1 block the binding of PD-1 on tumor-infiltrating NK cells and elevated PD-L1 on residual tumor cells, thereby synergistically enhancing the activity of NK cells and their cytotoxicity against tumor cells, ultimately prolonging the survival of tumor-bearing mice. The gene discussed is PDCD1; the disease is neoplasm.